NOT KNOWN FACTUAL STATEMENTS ABOUT MBL77

Are BTK and PLCG2 mutations required and sufficient for ibrutinib resistance in Persistent lymphocytic leukemia?Persistent lymphocytic leukemia (CLL) is actually a lymphoid malignancy characterised by the proliferation and accumulation of experienced CD5+ B cells within the blood, bone marrow and lymphoid tissues. The diagnosis of CLL demands the e